Severe Women Injury Factors Test (SWIFT) (SWIFT)
Descriptive Factors of Intimate Partner Violence on Women Related to "Incapacité Totale de Travail" : Multicenter Prospective Study
Intimate partner violence is a real public health problem, and affects all socio-cultural backgrounds It is defined by behavior within an intimate relationship that causes physical, psychological or sexual harm or suffering to the people in that relationship.
Several risk factors exist such as young age, low level of education, exposing to violence during childhood, pregnancy or addictions.
Study Overview
Detailed Description
Routine screening is recommended with redaction of medical certificate in which doctor have to determine l'"Incapacité Totale de Travail" corresponding to the duration of discomfort (physical and psychological repercussions) in the activities of daily life.
It is a legal notion allows to rule on the responsibility of the author. The sentence is increased if the ITT is greater than 8 days.
Worldwide, 30% of women suffered violence whose most common form is intimate partner violence, but legal proceedings have been initiated in less than 25% of the cases.
The trauma of women victims of domestic violence worsens with the repetitions of assaults.
The investigators suppose that the duration of ITT is an indicator of the severity of the injuries sustained.
So, the investigators want to highlight the socio-demographic characteristics and describe the spouse abuse, and then related theese factors to " Incapacité Totale de Travail " (term used in law. It is a scale for assessing the importance of injuries).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Orléans, France, 45067
- Regional Hospital center of ORLEANS
-
Orléans, France
- Centre Hospitalier Régional d'Orléans (UMJ)
-
Tours, France
- CHRU de Tours (SAU)
-
Tours, France
- CHRU de Tours (UMJ)
-
Tours, France
- SOS Médecins Tours
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adult patients
- Admission to emergency for intimate partner violence
- Or consultation to SOS doctor for intimate partner violence
- Or consultation to medico-judicial unit for intimate partner violence
- No verbal opposition to inclusion
Exclusion Criteria:
- Non intimate partner violence
- Patient under guardianship or curatorship
- Non French speaker
- Coma or inability to express non-opposition
- Prior participation in another center
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Women consulting for spouse abuse
The study focuses on women consulting a doctor as part of spouse abuse, whatever the context (at the request of the police or not) or their motivation (medical or social).
|
It is a survey that the patient and doctor must complete.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Descriptive factors of intimate partner violence on women related to "Incapacité Totale de Travail"
Time Frame: Month 24
|
Highlight the socio-demographic characteristics and the violence suffered by women victims of intimate partner violence, and related this factors to " Incapacité Totale de travail "
|
Month 24
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Descriptive factors of intimate partner violence on women related to "Incapacité Totale de travail" for more than eight days.
Time Frame: Month 24
|
Highlight the socio-demographic characteristics and the violence suffered by women victims of intimate partner violence, and related this factors to an " Incapacité Totale de travail " for more than eight days.
|
Month 24
|
|
Spontaneus request of a medical certificate during the consultation.
Time Frame: Month 24
|
Determine the proportion of women asking for a medical certificate during the consultation.
|
Month 24
|
Collaborators and Investigators
Investigators
- Principal Investigator: Julien PASSERIEUX, Dr, Chr D'Orleans
Publications and helpful links
General Publications
- Leppakoski T, Paavilainen E, Astedt-Kurki P. Experiences of emergency care by the women exposed to acute physical intimate partner violence from the Finnish perspective. Int Emerg Nurs. 2011 Jan;19(1):27-36. doi: 10.1016/j.ienj.2010.02.006. Epub 2010 May 20.
- Saberi E, Eather N, Pascoe S, McFadzean ML, Doran F, Hutchinson M. Ready, willing and able? A survey of clinicians' perceptions about domestic violence screening in a regional hospital emergency department. Australas Emerg Nurs J. 2017 May;20(2):82-86. doi: 10.1016/j.aenj.2017.02.001. Epub 2017 Mar 6.
- Lopez-Ossorio JJ, Gonzalez Alvarez JL, Buquerin Pascual S, Garcia LF, Buela-Casal G. Risk factors related to intimate partner violence police recidivism in Spain. Int J Clin Health Psychol. 2017 May-Aug;17(2):107-119. doi: 10.1016/j.ijchp.2016.12.001. Epub 2017 Jan 31.
- Lyons VH, Kernic MA, Rowhani-Rahbar A, Holt VL, Carone M. Use of multiple failure models in injury epidemiology: a case study of arrest and intimate partner violence recidivism in Seattle, WA. Inj Epidemiol. 2019 Aug 12;6:36. doi: 10.1186/s40621-019-0215-x. eCollection 2019.
- Choi AW, Lo BC, Wong JY, Lo RT, Chau PC, Wong JK, Lau CL, Kam CW. Clinical Features of Heterosexual Intimate Partner Violence Victims With Escalating Injury Severity. J Interpers Violence. 2021 Sep;36(17-18):8585-8605. doi: 10.1177/0886260519850539. Epub 2019 May 29.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CHRO-2021-02
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.